Lv21
140 积分 2023-05-26 加入
Degrader–Antibody Conjugates: Emerging New Modality
1天前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
1天前
已完结
Scalable Synthesis of ABBV-105 Enabled by Suzuki Coupling with Low Pd Loading, Ru-Catalyzed Asymmetric Hydrogenation, and Acylation Using Impinging Jet
2天前
已完结
The antibody–drug conjugate landscape
6天前
已完结
Axial Chirality in the Sotorasib Drug Substance, Part 1: Development of a Classical Resolution to Prepare an Atropisomerically Pure Sotorasib Intermediate
9天前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
9天前
已完结
Degrader-antibody conjugates
9天前
已完结
Development of Preclinical Formulations for Toxicology Studies
15天前
已完结
Cyclic Peptides in Pipeline: What Future for These Great Molecules?
20天前
已完结
Inhibition of neuronal nitric oxide synthase by 7-methoxyindazole and related substituted indazoles
23天前
已完结
皖公网安备34019202002308
